Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT01389050
Eligibility Criteria:
Inclusion Criteria:
* Pathologically (histologically or cytologically) proven diagnosis of sarcoma (except for GIST, Ewing's sarcoma and rhabdomyosarcoma) within the retroperitoneum. These include patients with locally recurrent disease
* Planned to receive pre-operative radiotherapy
* Will undergo a planning CT
* Karnofsky Performance Status of ≥ 70 within 28 days prior to study entry
* No systemic chemotherapy given prior to pre-operative radiotherapy
* Able to provide written, informed consent
* Women of childbearing potential and men who are sexually active must practice adequate contraception.
Exclusion Criteria:
* Tumor pathology of GIST, Ewing's sarcoma or rhabdomyosarcoma
* Metastatic disease to the retroperitoneum from a primary sarcoma not originating from the retroperitoneum
* Systemic chemotherapy given prior to pre-operative radiotherapy.
* Intent on giving chemotherapy ≤ 12 months from the completion of radiotherapy
* Inability to undergo a 4D-CT simulation
* KPS \< 70
* Unable to provide informed consent
* Pregnant women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01389050
Study Brief:
Protocol Section:
NCT01389050